Suven Life Sciences Ltd

Suven Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Suven Life Sciences Ltd experienced a notable decline today, touching an intraday low of Rs 318.2, reflecting a sharp price pressure that outpaced the broader market and its sector peers.

From a 52-week low of Rs 124.35 to a fresh peak of Rs 371, Suven Life Sciences Ltd has surged 33.78% over the past year, significantly outperforming the Sensex which declined 6.37% in the same period. This rally culminated in the stock hitting a new 52-week high on 13 Jul 2026, driven by a confluence of strong technical signals and sustained price momentum.

Suven Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Suven Life Sciences Ltd has reached a significant milestone by touching its all-time high price of Rs 367.5 on 13 Jul 2026, marking a remarkable phase in the company’s market journey. This achievement reflects sustained gains and robust trading momentum within the healthcare services sector.

Surging to an intraday peak of Rs 363.95 on 10 Jul 2026, Suven Life Sciences Ltd has marked a significant milestone by reaching a fresh 52-week high. This achievement caps a sustained rally that has seen the stock appreciate 35.37% over the past year, comfortably outperforming the Sensex’s decline of 6.79% during the same period.

Suven Life Sciences Ltd has reached a significant milestone by touching its all-time high price on 10 July 2026, reflecting a robust upward trajectory in the healthcare services sector. The stock’s performance over recent months underscores a period of sustained gains and market outperformance.

The Sensex rose 0.61% on 09 Jul 2026, yet Suven Life Sciences Ltd outpaced the broader market with a 7.15% gain, touching an intraday high of Rs 345.9. This 5.14-percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Surging to an intraday peak of Rs 345.9 on 9 Jul 2026, Suven Life Sciences Ltd has marked a significant milestone by reaching a fresh 52-week high. This achievement comes amid a backdrop of robust technical momentum and sustained outperformance relative to its sector and the broader market.

Suven Life Sciences Ltd has reached a significant milestone by touching an all-time high price of ₹342.00 on 09 Jul 2026, marking a remarkable surge in its market valuation and reflecting sustained bullish momentum in the healthcare services sector.

The Sensex advanced 0.64% on 3 Jul 2026, yet Suven Life Sciences Ltd outpaced the broader market with a 9.33% gain, reaching an intraday high of Rs 328.8. This 8.13-percentage-point outperformance over the Healthcare Services sector highlights a distinctly stock-specific rally rather than a market-wide lift.

With a decisive surge to Rs 321.7 on 3 Jul 2026, Suven Life Sciences Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces its sector and the broader market.

Suven Life Sciences Ltd, a key player in the healthcare services sector, reached a significant milestone on 3 July 2026 by touching an all-time high price of Rs.316.8. This achievement reflects the company’s strong market performance and sustained upward momentum over recent months.

With a decisive surge that pushed it within a hair’s breadth of its 52-week high at Rs 303 on 2 Jul 2026, Suven Life Sciences Ltd has demonstrated robust price momentum, outpacing its sector and the broader market. This rally is underpinned by a confluence of bullish technical indicators across multiple timeframes, signalling sustained strength in the stock’s upward trajectory.

Suven Life Sciences Ltd has reached a significant milestone by touching its all-time high price of Rs 305.00 on 02 Jul 2026, marking a remarkable phase in the company’s market journey within the healthcare services sector.

Suven Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.